A42.0 Pulmonary actinomycosis

Name of the Condition

• Pulmonary actinomycosis

Summary

Pulmonary actinomycosis is a chronic bacterial infection caused by Actinomyces species, typically resulting in granulomatous inflammation and abscess formation within the lungs. The condition progresses slowly and may involve adjacent tissues if left untreated.

Causes

Pulmonary actinomycosis is caused by anaerobic or microaerophilic bacteria from the genus Actinomyces, most commonly Actinomyces israelii. These bacteria are part of the normal flora in the mouth and upper respiratory tract but can invade lung tissue following aspiration, trauma, or other disruptions.

Risk Factors

• Chronic aspiration (e.g., from alcoholism or impaired swallowing)
• Poor oral hygiene or dental infections
• Immunocompromised states (e.g., diabetes, HIV)
• Pre-existing lung diseases (e.g., bronchiectasis, emphysema)
• Thoracic surgery or trauma
• Long-term steroid use

Symptoms

• Persistent cough, often with sputum production
• Chest pain or discomfort
• Fever, night sweats, or weight loss
• Hemoptysis (coughing up blood)
• Fatigue or malaise
• Shortness of breath (in severe cases)

Diagnosis

Diagnosis is based on clinical presentation, imaging (e.g., chest X-ray or CT showing nodules, cavities, or pleural involvement), and microbiological confirmation (e.g., sputum or tissue culture identifying Actinomyces species). Biopsy may be required to rule out malignancy.

Treatment Options

• Antibiotics: Prolonged courses (6–12 months) of penicillin or other beta-lactams are standard.
• Surgical intervention: Drainage of abscesses or resection of infected tissue may be necessary in severe cases.
• Supportive care: Management of symptoms (e.g., pain relief, oxygen therapy) and monitoring for complications.

Prognosis and Follow-Up

With appropriate treatment, prognosis is generally good, though recovery may be slow. Follow-up includes monitoring for recurrence, especially if treatment is incomplete. Long-term outcomes depend on the extent of lung involvement and underlying health status.

Complications

• Lung abscess formation
• Bronchopleural fistula
• Spread to adjacent structures (e.g., chest wall, mediastinum)
• Chronic respiratory impairment
• Secondary bacterial infections

Lifestyle & Prevention

• Maintain good oral hygiene to reduce bacterial load.
• Avoid aspiration (e.g., by addressing swallowing difficulties).
• Manage underlying conditions (e.g., diabetes) to support immune function.
• Seek prompt treatment for respiratory infections.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent respiratory symptoms (e.g., cough, chest pain), unexplained weight loss, or fever lasting more than a few days. Early evaluation is critical to prevent progression.

Tips for Medical Coders

Document the clinical findings supporting pulmonary involvement, including imaging results, microbiological confirmation, and treatment details. Ensure the code A42.0 is used when the infection is localized to the lungs, with clear differentiation from other actinomycosis sites (e.g., cervicofacial or abdominal).